Logo image
Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors
Journal article   Peer reviewed

Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors

D.R. Davies, K.M. Wyatt, J.E. Jardine, I.D. Robertson and P.J. Irwin
Journal of the American Animal Hospital Association, Vol.40(2), pp.124-130
2004
url
Link to Published Version *Subscription may be requiredView

Abstract

Twenty-seven dogs with inadequately excised, cutaneous mast cell tumors (MCT; 20 residual microscopic disease, seven marginal excision) were treated with a vinblastine and prednisolone chemotherapeutic protocol. Twenty dogs were available for follow-up examination after 12 months. One dog suffered local recurrence of the tumor, four dogs developed new cutaneous tumors, and one dog had both events. Fourteen dogs were free of MCT. There was no confirmed tumor-related mortality. Although toxicity from the chemotherapy was generally mild, one dog died of sepsis during treatment.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
3 Agriculture, Environment & Ecology
3.232 Veterinary Sciences
3.232.1281 Veterinary Reproductive Health
Web Of Science research areas
Veterinary Sciences
ESI research areas
Plant & Animal Science
Logo image